Cargando…

More Than a Decade of GeneXpert(®) Mycobacterium tuberculosis/Rifampicin (Ultra) Testing in South Africa: Laboratory Insights from Twenty-Three Million Tests

This study seeks to describe the rollout and current state of South Africa’s GeneXpert molecular diagnostic program for tuberculosis (TB). Xpert MTB/RIF was introduced in 2011 with a subsequent expansion to include extra-pulmonary and paediatric testing, followed by Xpert MTB/RIF Ultra in 2017. Thro...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Manuel Pedro, Cassim, Naseem, Ndlovu, Silence, Marokane, Puleng Shiela, Radebe, Mbuti, Shapiro, Anne, Scott, Lesley Erica, Stevens, Wendy Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605857/ https://www.ncbi.nlm.nih.gov/pubmed/37892074 http://dx.doi.org/10.3390/diagnostics13203253

Ejemplares similares

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

Interpretation of Discordant Rifampicin Susceptibility Test Results Obtained Using GeneXpert vs Phenotypic Drug Susceptibility Testing
por: Huo, Fengmin, et al.
Publicado: (2020)

Rapid Evaluation of the Xpert(®) Xpress CoV-2 plus and Xpert(®) Xpress CoV-2/Flu/RSV plus Tests
por: Noble, Lara Dominique, et al.
Publicado: (2022)

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
por: Mukhida, Sahjid, et al.
Publicado: (2022)

Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
por: Gwaza, Gamuchirai P., et al.
Publicado: (2023)

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

Old test for the diagnosis of novel corona virus infection: Role of GeneXpert in COVID-19 testing
por: Singh, Harpreet, et al.
Publicado: (2020)

An observational report of universal GeneXpert testing of inpatients with diagnosed or presumptive TB in the Philippines
por: Thi, Aye Myat, et al.
Publicado: (2020)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
por: Atashi, S., et al.
Publicado: (2017)

Detection of Mycobacterium Tuberculosis and Rifampicin-Resistant Gene among Hemodialysis Patients in Khartoum, Sudan: Using GeneXpert Assay
por: Mohamed, Balsam Adil, et al.
Publicado: (2020)

Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia
por: Selfegna, Sebsib, et al.
Publicado: (2022)

Comparative Performance of Line Probe Assay and GeneXpert in the Detection of Rifampicin Monoresistance in a TB-Endemic African Country
por: Mchaki, Betty R., et al.
Publicado: (2022)

Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
por: Patel, Sakshi, et al.
Publicado: (2023)

Prevalence of rifampicin resistant pulmonary tuberculosis using geneXpert assay in Ethiopia, a systematic review and meta-analysis
por: Demelash, Maritu, et al.
Publicado: (2023)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay
por: Gous, Natasha, et al.
Publicado: (2016)

Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review
por: Brown, Scott, et al.
Publicado: (2021)

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017
por: Farra, Alain, et al.
Publicado: (2019)

Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal
por: Sah, Shiv Kumar, et al.
Publicado: (2020)

HIV Viral Load Testing in the South African Public Health Setting in the Context of Evolving ART Guidelines and Advances in Technology, 2013–2022
por: Hans, Lucia, et al.
Publicado: (2023)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Molecular Epidemiology of Rifampicin Resistance in Mycobacterium tuberculosis Using the GeneXpert MTB/RIF Assay from a Rural Setting in India
por: Reddy, Raghuprakash, et al.
Publicado: (2017)

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya
por: Aricha, S. A., et al.
Publicado: (2019)

Using quality improvement to improve the utilisation of GeneXpert testing at five lab hubs in Northern Uganda
por: Karamagi, Esther, et al.
Publicado: (2017)

Validation of GeneXpert testing for SARS-CoV-2 RNA in eight hospital laboratories in Oman
por: Al-Kindi, Nawal, et al.
Publicado: (2021)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
por: Masenga, Sepiso K., et al.
Publicado: (2017)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Impact of the GeneXpert(®) MTB/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories
por: Berra, Thaís Zamboni, et al.
Publicado: (2021)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda
por: Izudi, Jonathan, et al.
Publicado: (2020)

Establishing the cost of Xpert MTB/RIF mobile testing in high-burden peri-mining communities in South Africa
por: Cassim, Naseem, et al.
Publicado: (2021)

Clinical Profile, Yield of Cartridge-based Nucleic Acid Amplification Test (GeneXpert), and Outcome in Children with Tubercular Meningitis
por: Soma, Santosh K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qrs2bn104sbkj3efpeo541l8o